* Read the January 2010 MAPS Email Newsletter in the MAPS email news archive * December 17, 2010: Eighth Subject Enrolled in LSD Trial The eighth subject has been enrolled in the MAPS-sponsored clinical …
Investigators: Euphrosyne Gouzoulis-Mayfrank, MD and Mark Geyer, PhD Aachen, Germany and UC San Diego – La Jolla, California Sponsor: Heffter A study with healthy volunteers with two different hallucinogens …
Investigators: Franz Vollenweider, MD and Mark Geyer, PhD Sponsor: Heffter Psychiatric University Hospital – Zrich, Switzerland and UC San Diego – La Jolla, California Contact: Franz Vollenweider, …
Investigator: John Halpern, MD, Harrison Pope, MD Harvard Medical School – Cambridge, Massachussetts Contact: Sponsor: Heffter, NIDA, Harvard Medical School, MAPS Investigators have begun neuropsychological …
Contact:R. Andrew Sewell MD Sponsor: MAPS Inspired by reports from the cluster headache community that ingestion of seeds containing LSA (Hawaiian baby woodrose, morning glory, Rivea corymbosa) terminates …
Psychedelic Review,Vol. I, No. 1, June 1963 (complete pdf) Editorial Statement of Purpose “Can This Drug Enlarge Man’s Mind?”, Gerald Heard The Subjective After-Effects of Psychedelic …
Click here to access the investigator’s brochure (or “IB”) for psilocybin commissioned by MAPS and intended to be submitted to FDA and institutional review boards or ethics boards. The IB …
For information about currently ongoing psilocybin research by the Heffter Research Institute, visit heffter.org.
Generous donations have been made by Robert Barnhart ($125,000), Kevin Herbert ($18,750), Vanja Palmers ($10,000), Fredi Muller (10,000 SF), Amanda Feilding/Beckley Foundation (5000 Euros), and Anonymous …
Rick Doblin’s undergraduate thesis (New College of Florida,1987) consisted of interviews and questionnaires administered to most of the subjects in Dr. Walter Pahnke’s study twenty-five+ years …
Three letters in response to O'Suilleabhain and Giller 2003 and Kish 2003 Movement Disorders; Published On-line Sept 13, 2004 Letter #1 DOI: 10.1002/mds.20223 Ecstasy Use-Parkinson's Disease Link Tenuous …
Minimum Informational Requirements for Establishing an FDA Drug Master File for Cannabis: Questions To Be Answered by Potential Manufacturers Clarify how the chemical constituents of plant material were …